$24.000
-0.653 (-2.72%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
DNLI-Prognose durch Analyse ähnlicher Charts
Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.61 (-1.61%). The 1-week path is $24.72 (+2.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Denali Therapeutics Inc-Aktien kaufen?
Denali Therapeutics Inc (DNLI) is a good buy right now due to its recent revenue growth of $3.6 million in Q2 2026, which exceeded expectations by $1.41 million, and a gross margin of 76.61%, indicating strong profitability potential. However, the main risk is the negative net income margin of -3539.21%, which reflects ongoing losses that investors should consider.
DNLI schloss am Friday bei $24.00, nachdem der Kurs -2.72% fallen
Denali Therapeutics Inc (DNLI) last closed at $24, losing -2.72%. These facts feed the 1-day and 1-week DNLI price prediction above.
Analystenkonsens
Denali Therapeutics Inc (DNLI): 3 Kaufen, 1 Halten, 0 Verkaufen. Ausblick: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Denali Therapeutics Inc (DNLI) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf DNLI am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für DNLI
Historically the probability of a positive August return for DNLI is 66.67%. August offers the highest probability of a positive month at 66.67%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.